Develops and commercializes innovative therapies for rare genetic diseases, focusing on unmet medical needs. Offers treatments for conditions like phenylketonuria, hemophilia, and mucopolysaccharidosis.
Notice Date
September 3, 2024
—
November 1, 2024
Manufacturing
105 Digital Drive Novato CA 94949
California
Marin County
